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Introduction
The immunoregulatory protein T cell immunoglobulin-
and mucin-domain-containing molecule-3 (Tim-3) con-
tributes towards T cell exhaustion in several chronic dis-
eases, including melanoma [1]. NK cells from the latter
were shown to be functionally impaired/exhausted, as
they failed to proliferate, produce cytokines or kill target
cells. In addition they down regulated activating recep-
tors (NKG2D and NKp46) and upregulated inhibitory
receptors (KIRB1, KIRNKAT2 and Tim-3). Notably Tim-
3 blockade reversed this exhausted phenotype, implicat-
ing this molecule as a major checkpoint inhibitor in
advanced melanoma [2]. To further evaluate NK cell phe-
notype and function as a consequence of progressive
melanoma, we monitored NK cells from a large cohort of
patients with stage I-IV melanoma tested the association
between NK cell phenotype and clinicopathological vari-
ables associated with melanoma prognosis. Expression of
MICA (NKG2D ligand) and HMGB1 (Tim-3 ligand) in
the plasma/sera of our main cohort was also monitored
in an independent validation cohort.
Methods
NK cells were purified from the peripheral blood of mela-
noma patients. They were evaluated for the expression of
activating and inhibitory receptors. Cytotoxicity was mea-
sured by Lamp-1 expression. IFN-g production was mea-
sured after 4h stimulation with rhIL-12. Proliferation was
quantified by CFSE after 6 days in the presence of rhIL-2.
MICA and HMGB1 expression on patients’ plasma/sera
was measured by ELISA. Event-time distributions were
estimated with the use of the Kaplan-Meier method. Two
tailed t-test unpaired was used to compare samples from
different stages.
Results
NK cells gradually develop a phenotypic and functional
profile consistent with progressive exhaustion, from stage
I to stage IV characterized by: 1) up-regulation of inhibi-
tory receptors (Tim-3, KIRB1 and KIRNKAT2); 2) down-
regulation of activating receptors (NKG2D and NKp46);
3) loss of IFN-g production, proliferation and cytotoxicity.
Interestingly, the expression of Tim-3 is higher, while the
cytotoxicy and IFN-ϒ production is reduced in patients
with melanomas thicker than 1mm. Moreover, higher
expression of Tim-3 and KIRB1, and a lower cytotoxic
ability and T-bet expression is associated with local or dis-
tant metastases. Higher expression of MICA in the plasma
was associated with worse prognosis, as was validated in
an independent cohort (Figure 1).
Conclusions
These data demonstrate that NK cells become progres-
sively exhausted in the context of melanoma progression
and that Tim-3 blockade possibly earlier in disease may
have some benefit on innate immune function. Finally,
our data suggest that soluble MICA is a potential prog-
nostic marker which may contribute to the NK cell
exhaustion through its interactions with NKG2D.
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Figure 1 Independent validation cohort
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